Cerebrolysin recall: Sterility Concern
CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Why was Cerebrolysin recalled?
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #1110202004 Exp 12/10/2020
- Product
- CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
- Recalling firm
- Advanced Nutriceuticals, LLC
- Quantity
- 1 vial
- Distribution
- CA, CO, FL, IN, KY, OH, TX
- Recall date
- December 23, 2020
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)